Tertiary hyperparathyroidism & postoperative hypocalcemia
Brock Lanier, M.D.
MCV/VCU Department of Surgery M&M
12 April 2012
1
2
• HPI: 68 y/o woman referred for surgical evaluation and management of tertiary hyperparathyroidism.
• ERSD (HTN) and s/p DDRTx (1/3/2011). Renal allograft function has been excellent (see next slide).
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationPre-hospital evaluation.
4
• HPI: 68 y/o woman referred for surgical evaluation and management of tertiary hyperparathyroidism.
• ERSD (HTN) and s/p DDRTx (1/3/2011). Renal allograft function has been excellent.
• Post transplant course significant for persistent hyperCa2+. Serum PTH values markedly elevated (see next slides).
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationPre-hospital evaluation.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Post DDRTx serum Ca2+ (mg/dL)
5
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Post DDRTx serum PTH (pg/mL)
6
7
• HPI: 68 y/o woman referred for surgical evaluation and management of tertiary hyperparathyroidism.
• ERSD (HTN) and s/p DDRTx (1/3/2011). Renal allograft function has been excellent.
• Post transplant course significant for persistent hyperCa2+. Serum PTH values markedly elevated.
• Pt referred to surgical oncology clinic for evaluation and mgmt thereof.
• Surgical intervention recommended but deferred by patient x several months (Aug 2011 until Feb 2012).
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationPre-hospital evaluation.
8
• PMHx: HTN, ESRD (previous PD, now functional allograft), post-txp DM, tertiary hyperparathyroidism.
• PSHx: DDRTx (1/2011), Tenkoff catheter insertion and removal, C-section x2.
• Meds: Prednisone 10 mg qd, FK 3 mg bid, MMF 750 mg bid, Sensipar 60 mg bid, ASA, lisinopril, Norvasc, Glipizide, famotidine, KCl.
• NKDA
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationPre-hospital evaluation.
9
• FamHx: HTN, DM, CVA in several family members, no h/o malignancy or endocrine dysfxn.
• Social hx: Married w/ adult children. Retired elementary school teacher for special needs children. Denies tobacco, EtOH, and illicit drug use.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationPre-hospital evaluation.
10
• 3/23/2012 OR: neck exploration, parathyroidectomy x4, LUQ abdominal wall SQ autograft implant.- Path: hyperplasia x 4 glands.- Standard postop Ca2+ repletion protocol initiated.
o CaCl 2 gm IV q4 h started and then titrated down and PO supplementation stated as serum Ca2+ levels allow.
o Often 5-7 days required before eucalcemia is achieved.
• POD #5: Febrile, UTI treated and resolved with ABX.• POD #8: D/c home.
- Calcium trended down postoperative (see next slide).
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationHospital course.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
POD #0-8 serum Ca2+ (mg/dL) trend
11
12
• 3/23/2012 OR: neck exploration, parathyroidectomy x4, LUQ abdominal wall SQ autograft implant.- Path: hyperplasia x 4 glands.- Standard postop Ca2+ repletion protocol initiated.
o CaCl 2 gm IV q4 h started and then titrated down and PO supplementation stated as serum Ca2+ levels allow.
o Often 5-7 days required before eucalcemia is achieved.
• POD #5: Febrile, UTI treated and resolved with ABX.• POD #8: D/c home.
- Calcium trended down postoperative.- At time of d/c, prn repletion requirements were minimal
(single Ca gluc 2 gm x1/d); PO repletion was stable (2400 mg PO qid); and calcitriol was increased (1 ug PO bid).
- D/c plans included close f/u lab values as outpatient.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationHospital course.
13
• 4/5/2012 (POD #13): Re-admit for symptomatic hypocalcemia (numbness and tingling in B fingers, next slide).
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationHospital re-admission.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Postoperative serum Ca2+ (mg/dL) trend
14
15
• 4/5/2012 (POD #13): Re-admit for symptomatic hypocalcemia (numbness and tingling in B fingers).- IV repletions initiated with symptom resolution.- PO repletions increased (calcitriol to 1.5 ug PO bid).
• 4/6/2012 (POD #14): last IV dose required.• 4/7 – 4/9/2012: stable, then increasing serum Ca2+
(next slide).
: Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationHospital re-admission.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Re-admission serum Ca2+ (mg/dL) trend
16
17
• 4/5/2012 (POD #13): Re-admit for symptomatic hypocalcemia (numbness and tingling in B fingers).- IV repletions initiated with symptom resolution.- PO repletions increased (calcitriol to 1.5 ug PO bid).
• 4/6/2012 (POD #14): last required IV dose.• 4/7 – 4/9/2012: stable then increasing serum Ca2+.• 4/9/2012 (POD #17): d/c home, eucalcemic on stable
PO regimen (PO only x ~ 72 hr). Alternative plans for outpatient surveillance implemented.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Case presentationHospital re-admission.
18
• Tertiary (HPT) most often occurs in the setting after renal txp.
• It is (almost always) caused by hyperplasia of the (four) parathyroid glands. Indications for operation, next slide.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Tertiary hyperparathyroidism (HPT)Refractory disease after RTx, surgically treated.
19
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Tertiary hyperparathyroidism (HPT)S. C. Pitt, R. S. Sippel, and H. Chen, Surg Clin 2009, PMID 19836494.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Post DDRTx serum Ca2+ (mg/dL)
20
21
• Tertiary (HPT) most often occurs in the setting after renal txp.
• It is (almost always) caused by hyperplasia of the (four) parathyroid glands. Indications for operation, next slide.
• Reports indicate about 1-5% of RTx patients require surgical management.
• “Hungry bone syndrome” (accelerated bone re-mineralization) and delayed autograft recovery/function both increase the risk for transient hypocalcemia.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Tertiary hyperparathyroidism (HPT)Refractory disease after RTx, surgically treated.
22
• For this reason patients are placed on an aggressive Ca2+ supplementation schedule postoperatively, initially IV then transitioned to PO.
• Only a small fraction of patients (<5%) require subsequent surgical intervention, i.e. autograft re-excision for persistent HPT.
Tertiary hyperparathyroidism & postoperative symptomatic hypocalcemia
Tertiary hyperparathyroidism (HPT)Refractory disease after RTx, surgically treated.